Physostigmine versus diazepines for anticholinergic poisoning.
Oakley
P
P
D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D000929:Antidepressive Agents, Tricyclic / Q000506:poisoning*; D000931:Antidotes / Q000627:therapeutic use*; D001569:Benzodiazepines; D018680:Cholinergic Antagonists / Q000506:poisoning*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D015897:Comorbidity; D003693:Delirium / Q000139:chemically induced* / Q000188:drug therapy*; D004357:Drug Synergism; D004638:Emergency Treatment / Q000379:methods; D006801:Humans; D007902:Length of Stay; D010830:Physostigmine / Q000627:therapeutic use*; D012107:Research Design; D012640:Seizures / Q000139:chemically induced
D014151:Anti-Anxiety Agents; D000929:Antidepressive Agents, Tricyclic; D000931:Antidotes; D018680:Cholinergic Antagonists; D002800:Cholinesterase Inhibitors; D001569:Benzodiazepines; D010830:Physostigmine